The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes

Circulation Research

Volumn 83, Issue 10, 1998, Pages 1047-1058

  Davisson, Robin L ^a   Yang, Gongyu ^a   Beltz, Terry G ^a   Cassell, Martin D ^a   Johnson, Alan Kim ^a   Sigmund, Curt D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Angiotensin; Blood pressure; Genetics; Pharmacology; Transgenic mice

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; ARGIPRESSIN; GANGLION BLOCKING AGENT; HEXAMETHONIUM; LOSARTAN; RENIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART RATE; HYPERTENSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENE; TRANSGENIC MOUSE;

EID: 0032538972     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.10.1047     Document Type: Article

References (58)

1. Reid IA, Morris BJ, Ganong WF. The renin-angiotensin system. Annu Rev Physiol. 1978;40:377-410.
2. Phillips MI. Function of angiotensin in the central nervous system. Annu Rev Physiol. 1987;49:413-435.
3. Unger T, Rascher W, Schuster C, Pavlovitch R, Schomig A, Dietz R, Ganten D. Central blood pressure effects of substance P and angiotensin II: role of the sympathetic nervous system and vasopressin. Eur J Pharmacol. 1981;71:33-42.
4. Falcon JC 2nd, Phillips MI, Hoffman WE, Brody MJ. Effects of intraventricular angiotensin II mediated by the sympathetic nervous system. Am J Physiol. 1978;235:H392-H399.
5. Rowe BP, Grove KL, Saylor DL, Speth RC. Angiotensin II receptor subtypes in the rat brain. Eur J Pharmacol. 1990;186:339-342.
6. Bunnemann B, Fuxe K, Ganten D. The brain renin-angiotensin system: localization and general significance. J Cardiovasc Pharmacol. 1992; S51-S62.
7. Kakar SS, Riel KK, Neill JD. Differential expression of angiotensin II receptor subtype mRNAs (AT-1A and AT-1B) in the brain. Biochem Biophys Res Commun. 1992;185:688-692.
8. Johren O, Inagami T, Saavedra JM. AT1A, AT1B and AT2 angiotensin II receptor subtypes in rat brain. Neuroreport. 1995;6:2549-2552.
9. Muratani H, Averill DB, Ferrario CM. Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats. Am J Physiol. 1991;260:R977-R984.
10. Jensen LL, Harding JW, Wright JW. Role of paraventricular nucleus in control of blood pressure and drinking in rats. Am J Physiol. 1992;262: F1068-F1075.
11. Casto R, Phillips MI. Mechanism of pressor effects by angiotensin in the nucleus tractus solitarius of rats. Am J Physiol. 1985;247:R575-R581.
12. Toney GM, Porter JP. Effects of blockade of AT1 and AT2 receptors in brain on the central angiotensin II pressor response in conscious spontaneously hypertensive rats. Neuropharmacology. 1993;32:581-589.
13. 1 receptor mRNA inhibits central angiotensin induced thirst and vasopressin. Regul Pept. 1994;54:543-551.
14. Ferguson AV, Smith P. Cardiovascular responses induced by endothelin microinjection into area postrema. Regul Pept. 1990;27:75-85.
15. Simpson JB, Routtenberg A. Subfornical organ: site of drinking elicitation by angiotensin II. Science. 1973;181:1772-1775.
16. Phillips MI. Angiotensin in the brain. Neuroendocrinology. 1978;25: 354-377. Review.
17. Mangiapane ML, Simpson JB. Subfornical organ lesions reduce the pressor effect of systemic angiotensin II. Neuroendocrinology. 1980;31: 380-384.
18. Fink GD, Bruner CA, Mangiapane ML. Area postrema is critical for angiotensin-induced hypertension in rats. Hypertension. 1987;9:355-361.
19. Nishimura M, Milsted A, Block CH, Brosnihan KB, Ferrario CM. Tissue renin-angiotensin systems in renal hypertension. Hypertension. 1992;20: 158-167.
20. McDonald W, Wickre C, Aumann S, Ban D, Moffitt B. The sustained antihypertensive effect of chronic cerebroventricular infusion of angiotensin antagonist in spontaneously hypertensive rats. Endocrinology. 1980;107:1305-1308.
21. Okuno T, Nagahama S, Lindheimer MD, Oparil S. Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril. Hypertension. 1983;5:653-662.
22. Averill DB, Matsumura K, Ganten D, Ferrario CM. Role of area postrema in transgene hypertension. Hypertension. 1996;27:591-597.
23. Merrill DC, Thompson MW, Carney C, Schlager G, Robillard JE, Sigmund CD. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest. 1996;97:1047-1055.
24. Sigmund CD, Jones CA, Kane CM, Wu C, Lang JA, Gross KW. Regulated tissue- and cell-specific expression of the human renin gene in transgenic mice. Circ Res. 1992;70:1070-1079.
25. Yang G, Merrill DC, Thompson MW, Robillard JE, Sigmund CD. Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem. 1994;269:32497-32502.
26. Thompson MW, Smith SB, Sigmund CD. Regulation of human renin mRNA expression and protein release in transgenic mice. Hypertension. 1996;28:290-296.
27. Sigmund CD. Expression of the human renin gene in transgenic mice throughout ontogeny. Pediatr Nephrol. 1993;7:639-645.
28. Davisson RL, Kim HS, Krege JH, Lager DJ, Smithies O, Sigmund CD. Complementation of reduced survival, hypotension and renal abnormalities in angiotensinogen deficient mice by the human renin and human angiotensinogen genes. J Clin Invest. 1997;99:1258-1264.
29. Paxinos G, Watson CS. The Rat Brain in Stereotaxic Coordinates. 2nd ed. New York: Academic Press; 1986.
30. Samson WK. Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. Neuroendocrinology. 1985;40: 277-279.
31. Davisson RL, Nuutinen N, Coleman ST, Sigmund CD. Inappropriate splicing of a chimeric gene containing a large internal exon results in exon skipping in transgenic mice. Nucleic Acids Res. 1996;24: 4023-4028.
32. Winer BJ. Statistical Principles of Experimental Design. New York: McGraw-Hill Book Co; 1971:752-809.
33. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
34. Kondo KT, Okuno T, Eguchi T, Yasui T, Nakamura R, Surta T. Central hypertensive actions of angiotensin I, II and III in conscious rats. Endocrinol Jpn. 1979;26:713-717.
35. Head GA, Williams NS. Hemodynamic effects of central angiotensin I, II and III in conscious rabbits. Am J Physiol. 1992;263:R382-R389.
36. Steckelings U, Lebrun C, Qadri F, Veltmar A, Unger T. Role of brain angiotensin in cardiovascular regulation. J Cardiovasc Pharmacol. 1992; 19(suppl 6):S72-S79. Review.
37. Yang RH, Jin H, Wyss JM, Oparil S. Depressor effect of blocking angiotensin subtype 1 receptors in anterior hypothalamus. Hypertension. 1992;19:475-481.
38. Hartle DK, Brody MJ. The angiotensin II pressor system of the rat forebrain. Circ Res. 1984;54:355-366.
39. Ferguson AV, Renaud LP. Hypothalamic paraventricular nucleus lesions decrease pressor responses to subfornical organ stimulation. Brain Res. 1984;305:361-364.
40. Li Z, Ferguson AV. Subfornical organ efferents to paraventricular nucleus utilize angiotensin as a neurotransmitter. Am J Physiol. 1993; 265:R302-R309.
41. Lind RW, Swanson LW, Ganten D. Angiotensin II immunoreactivity in the neural afferents and efferents of the subfornical organ of the rat. Brain Res. 1984;321:209-215.
42. McKinley MJ, Badoer E, Vivas L, Oldfield BJ. Comparison of c-fos expression in the lamina terminalis of conscious rats after intravenous or intracerebroventricular angiotensin. Brain Res Bull. 1995;37:131-137.
43. Rowland NE, Li BH, Rozelle AK, Fregly MJ, Garcia M, Smith GC. Localization of changes in immediate early genes in brain in relation to hydromineral balance: intravenous angiotensin II. Brain Res Bull. 1994; 33:427-436.
44. Bishop VS, Hay M. Involvement of the area postrema in the regulation of sympathetic outflow to the cardiovascular system. Front Neuroendocrinol. 1993;14:57-75. Review.
45. Matsukawa S, Reid IA. Role of the area postrema in the modulation of the baroreflex control of heart rate by angiotensin II. Circ Res. 1990;67: 1462-1473.
46. Bruner CA, Fink GD. Cerebroventricular infusion of angiotensin antagonist does not influence hypertensive response to blood-borne angiotensin II. Brain Res. 1985;360:15-23.
47. Gorbea-Oppliger VJ, Fink GD. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II. J Pharmacol Exp Ther. 1995;273:611-616.
48. Van Houten M, Mangiapane ML, Reid IA, Ganong WF. [Sar, Ala]angiotensin II in cerebrospinal fluid blocks the binding of blood-borne [125I]angiotensin II to the circumventricular organs. Neuroscience. 1983; 10:1421-1426.
49. Fitts DA. Angiotensin II receptors in SFO but not in OVLT mediate isoproterenol-induced thirst. Am J Physiol. 1994;267:R7-R15.
50. Collister JP, Hornfeldt BJ, Osborn JW. Hypotensive response to losartan in normal rats: role of Ang II and the area postrema. Hypertension. 1996;27:598-606.
51. Gutkind JS, Kurihara M, Castren E, Saavedra JM. Increased concentration of angiotensin II binding sites in selected brain areas of spontaneously hypertensive rats. J Hypertension. 1988;6:79-84.
52. Tamura K, Umemura S, Nyui N, Yamakawa T, Yamaguchi S, Ishigami T, Tanaka S, Tanimoto K, Takagi N, Sekihara H, Murakami K, Ishii M. Tissue-specific regulation of angiotensinogen gene expression in spontaneously hypertensive rats. Hypertension. 1996; 27:1216-1223.
53. Senanayake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides. 1994;15:919-926.
54. Moriguchi A, Ferrario CM, Brosnihan KB, Ganten D, Morris M. Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene. Am J Physiol. 1994;267:R786-R791.
55. 1 arginine vasopressin agonist results in sustained hypertension. Am J Physiol. 1994;267:H751-H756.
56. 1 vasopressin receptors results in sustained hypertension. Am J Physiol. 1994;267:R1217-R1225.
57. Cowley AW Jr, Liard JF. Cardiovascular actions of vasopressin. In: Gash DM, Boer GJ, eds. Vasopressin. New York: Plenum; 1987:389-433.
58. Barron KW, Trapani AJ, Gordon FJ, Brody MJ. Baroreceptor denervation profoundly enhances cardiovascular responses to central angiotensin II. Am J Physiol. 1989;257:H314-H323.